Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
BIOSpektrum application article highlights HoloMonitor technology (in German)
PHI’s CSO, Kersti Alm, and Head of Communication, Lisa Bodily, have recently contributed to the June 2023 issue of the German BIOSpektrum journal. Their application article sheds light on how HoloMonitor’s technology is applied for non-invasive live cell analysis.
HoloMonitor is the most innovative MedTech Company in Scandinavia in 2023
We at PHI are humbled that the Global Health & Pharma Magazine has awarded us as the most innovative MedTech Company in Scandinavia in 2023!
Cytocentric measurement for regenerative medicine
PHI, together with our alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, global analytics company SAS and others, has recently published a paper in Frontiers in Medical Technology about the critical cell and process parameters for cell and tissue products as well as technologies available in Regenerative Medicine. Here we highlighted more about the “what, why and how” of cyctocentric measurement.
Technological developments in the rapidly evolving field of live-cell microscopy
Discover more about the developments in live-cell microscopy and how the HoloMonitor® technology is a gentle time-lapse imaging method for non-invasive, long-term and quantitative analysis of living cells.
The Scientist: Observing Cells in Their Natural State with Digital Holographic Cytometry
New blog article: Head over to The Scientist to read about observing cells in their natural state with digital holographic cytometry.
2022 publication highlights
In 2022, researchers around the world published 34 publications featuring HoloMonitor. We are thrilled to see how HoloMonitor helps scientists around the world explore new areas of study and address questions from cancer research to neuroscience.
HoloMonitor user Spotlight: Tianyan Wang
Tianyan talks about how digital holographic cytometry (DHC) and HoloMonitor data have been key in his Ph.D. thesis: Utility of Novel Drug Targets for Treatment of Metastatic Cancer.
Webinars in Chinese! – Everything you need to know about HoloMonitor
To help our customers who speak different languages, PHI and our local partner in China, Bio-Sun, held two webinars in Chinese to explain everything you need to know about HoloMonitor.
HoloMonitor User Spotlight: Francesco Pasqualini
Francesco Pasqualini, Associate Professor at University Pavia, tells how he applies HoloMonitor to see how ECM affects cells over a long time.
HoloMonitor user spotlight: Robert Judson-Torres
To be a mole or to be a melanoma? Dr. Robert Judson-Torres, Assistant Professor at Huntsman Cancer Institute, University of Utah, speaks about how HoloMonitor data has been key in his recent work.